LLY

1,039.57

+3.11%↑

JNJ

230.44

+0.17%↑

ABBV

215.27

+1.25%↑

UNH

383.89

+0.35%↑

AZN

189.87

+1%↑

LLY

1,039.57

+3.11%↑

JNJ

230.44

+0.17%↑

ABBV

215.27

+1.25%↑

UNH

383.89

+0.35%↑

AZN

189.87

+1%↑

LLY

1,039.57

+3.11%↑

JNJ

230.44

+0.17%↑

ABBV

215.27

+1.25%↑

UNH

383.89

+0.35%↑

AZN

189.87

+1%↑

LLY

1,039.57

+3.11%↑

JNJ

230.44

+0.17%↑

ABBV

215.27

+1.25%↑

UNH

383.89

+0.35%↑

AZN

189.87

+1%↑

LLY

1,039.57

+3.11%↑

JNJ

230.44

+0.17%↑

ABBV

215.27

+1.25%↑

UNH

383.89

+0.35%↑

AZN

189.87

+1%↑

Search

Medtronic PLC

Ouvert

SecteurSoins de santé

77.4 -0.51

Résumé

Variation du prix de l'action

24h

Actuel

Min

76.81

Max

78.2

Chiffres clés

By Trading Economics

Revenu

-231M

1.1B

Ventes

57M

9B

P/E

Moyenne du Secteur

21.598

49.701

BPA

0.89

Rendement du dividende

3.72

Marge bénéficiaire

12.675

Employés

95,000

EBITDA

124M

2.5B

Recommandations

By TipRanks

Recommandations

Achat

Prévisions sur 12 Mois

+35.04% upside

Dividendes

By Dow Jones

Rendement du dividende

Moyenne du Secteur

3.72%

2.39%

Prochains Résultats

3 juin 2026

Date du Prochain Dividende

10 juil. 2026

Date du Prochain Détachement de Dividende

26 juin 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-28B

99B

Ouverture précédente

77.91

Clôture précédente

77.4

Sentiment de l'Actualité

By Acuity

23%

77%

49 / 345 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Weak Bearish Evidence

Medtronic PLC Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

20 mai 2026, 13:49 UTC

Acquisitions, Fusions, Rachats

Medtronic to Buy SPR Therapeutics for About $650 Million

10 mars 2026, 11:19 UTC

Acquisitions, Fusions, Rachats

Medtronic to Buy Scientia Vascular in $550 Million Deal

17 févr. 2026, 12:43 UTC

Résultats

Medtronic 3Q Profit Falls Despite Higher Revenue

20 mai 2026, 13:15 UTC

Acquisitions, Fusions, Rachats

Medtronic Announces Intent To Acquire SPR Therapeutics, Inc., Expanding Care Options For People Living With Chronic Pain >MDT

20 mai 2026, 13:15 UTC

Acquisitions, Fusions, Rachats

Medtronic to Buy SPR Therapeutics for About $650 Million in Cash >MDT

22 avr. 2026, 11:27 UTC

Résultats

Intuitive Surgical Earnings Show Big Beats Don't Always Spark Stock Rallies -- Barrons.com

20 avr. 2026, 11:50 UTC

Acquisitions, Fusions, Rachats

Medtronic Completes Acquisition Of CathWorks, Expanding Its Leadership In Transforming Care For Patients With Cardiovascular Disease >MDT

24 mars 2026, 20:59 UTC

Résultats

Medtronic PLC Cuts FY26 View To Adj EPS $5.50-Adj EPS $5.54 >MDT

10 mars 2026, 10:46 UTC

Acquisitions, Fusions, Rachats

Medtronic: Scientia Deal Complements Neurovascular Portfolio >MDT

10 mars 2026, 10:46 UTC

Acquisitions, Fusions, Rachats

Medtronic: Scientia Deal Includes Potential Undisclosed Earn-Out, Milestone Payments >MDT

10 mars 2026, 10:45 UTC

Acquisitions, Fusions, Rachats

Medtronic: Scientia Vascular Acquisition Valued at $550 Million >MDT

10 mars 2026, 10:45 UTC

Acquisitions, Fusions, Rachats

Medtronic to Acquire Scientia Vascular >MDT

17 févr. 2026, 21:21 UTC

Résultats

These Stocks Are Today's Movers: Paramount, Masimo, Medtronic, Kyndryl, eToro, Genuine Parts, Southwest, and More -- Barrons.com

17 févr. 2026, 18:11 UTC

Résultats

Medtronic Posts Better-Than-Expected Earnings. Here's Why the Stock Is Falling. -- Barrons.com

17 févr. 2026, 14:48 UTC

Résultats

Medtronic Posts Better-Than-Expected Earnings. Here's Why the Stock Is Falling. -- Barrons.com

17 févr. 2026, 13:00 UTC

Résultats

Medtronic Posts Better-Than-Expected Earnings. Here's Why the Stock Is Falling. -- Barrons.com

17 févr. 2026, 12:05 UTC

Résultats

Medtronic Posts Better-Than-Expected Earnings. Here's Why the Stock Is Falling. -- Barrons.com

17 févr. 2026, 11:47 UTC

Résultats

Medtronic Sees 2026 EPS up 4.5%, Excluding Potential Impact From Tariffs >MDT

17 févr. 2026, 11:47 UTC

Résultats

Medtronic Still Sees FY26 Organic Revenue Up About 5.5% >MDT

17 févr. 2026, 11:46 UTC

Résultats

Medtronic FY26 View Includes Potential Impact From Tariffs of About $185M >MDT

17 févr. 2026, 11:46 UTC

Résultats

Medtronic Backs FY26 View of Adj EPS $5.62-Adj EPS $5.66 >MDT

17 févr. 2026, 11:46 UTC

Résultats

Medtronic Reiterates FY26 Organic Rev Growth, EPS Guidance >MDT

17 févr. 2026, 11:45 UTC

Résultats

Medtronic 3Q Adj EPS $1.36 >MDT

17 févr. 2026, 11:45 UTC

Résultats

Medtronic 3Q Neuroscience Portfolio Rev $2.56B >MDT

17 févr. 2026, 11:45 UTC

Résultats

Medtronic 3Q Organic Revenue Up 6.0% >MDT

17 févr. 2026, 11:45 UTC

Résultats

Medtronic 3Q Sales $9.02B >MDT

17 févr. 2026, 11:45 UTC

Résultats

Medtronic 3Q Diabetes Rev $796M >MDT

17 févr. 2026, 11:45 UTC

Résultats

Medtronic 3Q Cardiovascular Portfolio Rev $3.46B >MDT

17 févr. 2026, 11:45 UTC

Résultats

Medtronic 3Q Medical Surgical Portfolio Rev $2.17B >MDT

17 févr. 2026, 11:45 UTC

Résultats

Medtronic 3Q Net $1.14B >MDT

Comparaison

Variation de prix

Medtronic PLC prévision

Objectif de Prix

By TipRanks

35.04% hausse

Prévisions sur 12 Mois

Moyen 105.53 USD  35.04%

Haut 120 USD

Bas 86 USD

Basé sur 17 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

17 ratings

11

Achat

6

Maintien

0

Vente

Score Technique

By Trading Central

83.26 / 84.875Support & Résistance

Court Terme

Weak Bearish Evidence

Moyen Terme

Bullish Evidence

Long Terme

Bearish Evidence

Sentiment

By Acuity

49 / 345Classement par Soins de santé

Sentiment de l'Actualité

Très Fortes Indications Haussières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Medtronic PLC

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and other products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. The segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists; and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat other non-exclusive diseases and conditions; and patient monitoring and airway management products. The Diabetes Operating Unit segment provides insulin pumps and consumables, continuous glucose monitoring systems, and InPen, a smart insulin pen system. The company was founded in 1949 and is headquartered in Galway, Ireland.
help-icon Live chat